Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 20

1.

Spectrum of Trained Innate Immunity Induced by Low Virulence Candida Species Against Lethal Polymicrobial Intra-Abdominal Infection.

Lilly EA, Yano J, Esher SK, Hardie E, Fidel PL Jr, Noverr MC.

Infect Immun. 2019 May 13. pii: IAI.00348-19. doi: 10.1128/IAI.00348-19. [Epub ahead of print]

2.

Erratum for Savage et al., "Iron Restriction to Clinical Isolates of Candida albicans by the Novel Chelator DIBI Inhibits Growth and Increases Sensitivity to Azoles In Vitro and In Vivo in a Murine Model of Experimental Vaginitis".

Savage KA, Parquet MDC, Allan DS, Davidson RJ, Holbein BE, Lilly EA, Fidel PL Jr.

Antimicrob Agents Chemother. 2019 Jan 29;63(2). pii: e02508-18. doi: 10.1128/AAC.02508-18. Print 2019 Feb. No abstract available.

3.
4.

Immune Protection against Lethal Fungal-Bacterial Intra-Abdominal Infections.

Lilly EA, Ikeh M, Nash EE, Fidel PL Jr, Noverr MC.

MBio. 2018 Jan 16;9(1). pii: e01472-17. doi: 10.1128/mBio.01472-17.

5.

Synthesis, Antifungal Activity, and Biocompatibility of Novel 1,4-Diazabicyclo[2.2.2]Octane (DABCO) Compounds and DABCO-Containing Denture Base Resins.

Herman JL, Wang Y, Lilly EA, Lallier TE, Peters BM, Hamdan S, Xu X, Fidel PL Jr, Noverr MC.

Antimicrob Agents Chemother. 2017 Mar 24;61(4). pii: e02575-16. doi: 10.1128/AAC.02575-16. Print 2017 Apr.

6.

A Murine Model of Candida glabrata Vaginitis Shows No Evidence of an Inflammatory Immunopathogenic Response.

Nash EE, Peters BM, Lilly EA, Noverr MC, Fidel PL Jr.

PLoS One. 2016 Jan 25;11(1):e0147969. doi: 10.1371/journal.pone.0147969. eCollection 2016.

7.

Efficacy of the clinical agent VT-1161 against fluconazole-sensitive and -resistant Candida albicans in a murine model of vaginal candidiasis.

Garvey EP, Hoekstra WJ, Schotzinger RJ, Sobel JD, Lilly EA, Fidel PL Jr.

Antimicrob Agents Chemother. 2015 Sep;59(9):5567-73. doi: 10.1128/AAC.00185-15. Epub 2015 Jun 29.

8.

Fungal morphogenetic pathways are required for the hallmark inflammatory response during Candida albicans vaginitis.

Peters BM, Palmer GE, Nash AK, Lilly EA, Fidel PL Jr, Noverr MC.

Infect Immun. 2014 Feb;82(2):532-43. doi: 10.1128/IAI.01417-13. Epub 2013 Nov 11.

9.

Chemical screening identifies filastatin, a small molecule inhibitor of Candida albicans adhesion, morphogenesis, and pathogenesis.

Fazly A, Jain C, Dehner AC, Issi L, Lilly EA, Ali A, Cao H, Fidel PL Jr, Rao RP, Kaufman PD.

Proc Natl Acad Sci U S A. 2013 Aug 13;110(33):13594-9. doi: 10.1073/pnas.1305982110. Epub 2013 Jul 31.

10.

CD8 T cells and E-cadherin in host responses against oropharyngeal candidiasis.

Quimby K, Lilly EA, Zacharek M, McNulty K, Leigh JE, Vazquez JE, Fidel PL Jr.

Oral Dis. 2012 Mar;18(2):153-61. doi: 10.1111/j.1601-0825.2011.01856.x. Epub 2011 Sep 30.

11.

Fabrication of a multi-applicable removable intraoral denture system for rodent research.

Lee H, Yu A, Johnson CC, Lilly EA, Noverr MC, Fidel PL Jr.

J Oral Rehabil. 2011 Sep;38(9):686-90. doi: 10.1111/j.1365-2842.2011.02206.x. Epub 2011 Feb 17.

12.

Candida albicans forms biofilms on the vaginal mucosa.

Harriott MM, Lilly EA, Rodriguez TE, Fidel PL, Noverr MC.

Microbiology. 2010 Dec;156(Pt 12):3635-3644. doi: 10.1099/mic.0.039354-0. Epub 2010 Aug 12.

13.

Annexin-A1 identified as the oral epithelial cell anti-Candida effector moiety.

Lilly EA, Yano J, Fidel PL Jr.

Mol Oral Microbiol. 2010 Aug;25(4):293-304. doi: 10.1111/j.2041-1014.2010.00579.x.

14.

Chemokine receptor expression in HIV-positive persons with oropharyngeal candidiasis.

Lilly EA, Leigh JE, McNulty KM, Joseph SH, Mercante DE, Fidel PL Jr.

Oral Dis. 2006 Sep;12(5):493-9.

PMID:
16910921
15.

Assessment of the association between HIV viral load and CD4 cell count on the occurrence of oropharyngeal candidiasis in HIV-infected patients.

Mercante DE, Leigh JE, Lilly EA, McNulty K, Fidel PL Jr.

J Acquir Immune Defic Syndr. 2006 Aug 15;42(5):578-83.

PMID:
16837865
16.

Candida-induced oral epithelial cell responses.

Lilly EA, Leigh JE, Joseph SH, Fidel PL Jr.

Mycopathologia. 2006 Jul;162(1):25-32.

PMID:
16830188
17.

Oral epithelial cell antifungal activity: approaches to evaluate a broad range of clinical conditions.

Lilly EA, Shetty KV, Leigh JE, Cheeks C, Fidel PL Jr.

Med Mycol. 2005 Sep;43(6):517-23.

PMID:
16323309
18.

Oral and vaginal epithelial cell anti-Candida activity is acid labile and does not require live epithelial cells.

Yano J, Lilly EA, Steele C, Fortenberry D, Fidel PL Jr.

Oral Microbiol Immunol. 2005 Aug;20(4):199-205.

19.

Lack of evidence for local immune activity in oral hairy leukoplakia and oral wart lesions.

Lilly EA, Cameron JE, Shetty KV, Leigh JE, Hager S, McNulty KM, Cheeks C, Hagensee ME, Fidel PL Jr.

Oral Microbiol Immunol. 2005 Jun;20(3):154-62.

PMID:
15836516
20.

Tissue-associated cytokine expression in HIV-positive persons with oropharyngeal candidiasis.

Lilly EA, Hart DJ, Leigh JE, Hager S, McNulty KM, Mercante DE, Fidel PL Jr.

J Infect Dis. 2004 Aug 1;190(3):605-12. Epub 2004 Jun 25.

PMID:
15243938

Supplemental Content

Loading ...
Support Center